Digital Pathology Market: Current Analysis and Forecast (2021-2027)

The digital pathology market is expected to register a CAGR of around 10% over the period of 2021-2027. Digital pathology is a practice of pathology using digital imaging. The application of this breakthrough technology is ready to become the standard of care in the field of pathology. Digital pathology uses still images, live streaming of images, and more recently whole slide images (WSI). Clinical applications include making primary pathological diagnoses directly from digital images, remote pathology, archiving, and image analysis. Non-clinical applications include skills testing, research, and education. The growing adoption of digital pathology can be attributed to the rising prevalence of cancer coupled with a rapidly growing geriatric population. According to the United Nations, the 60+ aged population was 962 million in 2017 which is more than twice that it was in 1980 at 382 million. The number of elderly is expected to double again by 2050 and reach nearly 2.1 billion worldwide. Furthermore, the digital pathology market is anticipated to grow on account of the growing technological advancement, and demand for enhancing lab efficiency.

Based on product type, the market is classified into the scanner, software, and storage system. Amongst them, the scanner category accounted for a significant share of the market. The increase in R&D activities in the pharmaceutical & medical device industry and the surge in adoption of digital pathology systems contribute to the growth of the segment.

Based on application, the market is classified into teleconsultation, training, disease diagnosis, and drug discovery. The drug discovery category accounted for a significant share of the market due to an increase in the prevalence of rare diseases and growing R&D activities in the drug development process.

Based on end-users, the market is classified into pharmaceutical & biotechnology companies, academic and research, and hospitals. The pharmaceutical & biotechnology companies category accounted for a considerable share of the digital pathology market. The growth of this segment can be attributed to the growing adoption of digital pathology for drug discovery studies and drug toxicology testing.

For a better understanding of the market adoption of digital pathology market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the digital pathology industry and generated major revenue in 2020 owing to the presence of well-established market players and the increasing prevalence of cancer in the region.

Some of the major players operating in the market include 3dhistech Ltd., Danaher Corporation (Leica Microsystem), Glencoe Software Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, Perkinelmer Inc., F- Hoffmann La-Roche, Visiopharm A/S.